Pa Shun International Holdings Limited (0574)

Overview

Pa Shun International Holdings Limited operates as a noteworthy entity in the healthcare sector within the People’s Republic of China, focusing its efforts on pharmaceutical distribution and manufacturing. The company primarily involves itself in distributing pharmaceutical products across various channels such as wholesalers, franchise retail pharmacy chain stores, and hospitals, especially targeting the rural regions to ensure wide-reaching healthcare access. Its manufacturing segment is dedicated to producing pharmaceutical products, adhering to stringent quality standards to meet the healthcare needs efficiently. Originally founded as Pa Shun Pharmaceutical International Holdings Limited, it underwent a rebranding to its current name in June 2017, marking a new phase in its operational focus and expansion efforts. Established in 2011 with its headquarters nestled in Kwun Tong, Hong Kong, Pa Shun International Holdings Limited functions under the umbrella of Praise Treasure Limited, signifying its strategic importance and role within its parent entity’s portfolio.

Products and Services

Pa Shun International Holdings Limited offers a broad range of products and services across the pharmaceutical spectrum to address the diverse needs of the healthcare industry in rural and urban settings alike. While I cannot directly access or augment information from their official website or external databases to update this section with more specific offerings, below is an articulated overview based on their operational segments:

• Pharmaceutical Distribution: This segment encompasses the company’s core competency in distributing an extensive array of pharmaceutical products. Designed to support the healthcare infrastructure, it includes:
  • Comprehensive distribution services to wholesalers, ensuring that a wide variety of pharmaceutical goods are available for retail and medical use across the region.
  • Supply chain solutions for franchise retail pharmacy chain stores, optimising inventory levels and product availability to meet consumer demand effectively.
  • Targeted distribution efforts to hospitals and medical institutions in rural areas, aiming to bridge the healthcare gap and promote equitable access to essential medicines and healthcare products.
• Pharmaceutical Manufacturing: With a focus on quality and efficacy, the manufacturing segment is dedicated to the in-house production of pharmaceutical products. Leveraging advanced manufacturing technologies and adhering to global quality standards, this aspect of the company’s operations underscores its commitment to healthcare excellence through:
  • Development and production of pharmaceuticals under stringent quality control measures to ensure safety and effectiveness.
  • Innovation in pharmaceutical research and development, aiming to introduce new products that meet the evolving healthcare needs of the population.